blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3978529

EP3978529 - ANTI-CANINE PD-1 ANTIBODY BINDING WITH CANINE PD-1 [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  04.03.2022
Database last updated on 13.11.2024
FormerThe international publication has been made
Status updated on  11.12.2020
Most recent event   Tooltip06.08.2024New entry: Additional fee for renewal fee: despatch of communication + time limit 
Applicant(s)For all designated states
Beijing Sinogene Biotechnology Co., Ltd.
Rm. 310, Third Floor, 16th Building
No. 37 Chaoqian Road
Zhongguancun Science Park
Changping District
Beijing 102299 / CN
[2022/14]
Inventor(s)01 / MI, Jidong
Rm. 310, Third Floor, 16th Building, No. 37
Chaoqian Road Zhongguancun Science Park
Changping District
Beijing 102299 / CN
02 / ZHAO, Jianping
Rm. 310, Third Floor, 16th Building, No. 37
Chaoqian Road Zhongguancun Science Park
Changping District
Beijing 102299 / CN
03 / ZHENG, Min
Rm. 310, Third Floor, 16th Building, No. 37
Chaoqian Road Zhongguancun Science Park
Changping District
Beijing 102299 / CN
04 / HUANG, Fan
San Jose 725 San Aleso Avenue, Suite 3B
Sunnyvale California 94085 / US
 [2022/14]
Representative(s)Kilger, Ute
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[2022/14]
Application number, filing date20818997.703.06.2020
[2022/14]
WO2020CN94243
Priority number, dateCN20191048034903.06.2019         Original published format: CN201910480349
[2022/14]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020244562
Date:10.12.2020
Language:ZH
[2020/50]
Type: A1 Application with search report 
No.:EP3978529
Date:06.04.2022
Language:EN
[2022/14]
Search report(s)International search report - published on:CN10.12.2020
(Supplementary) European search report - dispatched on:EP30.08.2023
ClassificationIPC:C07K16/28, A61K39/395, A61P35/00
[2022/14]
CPC:
A61P35/00 (EP,CN,US); C07K16/2818 (EP,CN,US); A61K2039/505 (CN,US);
A61K2039/552 (CN,US); C07K2317/20 (CN,US); C07K2317/24 (EP);
C07K2317/56 (CN); C07K2317/565 (CN,US); C07K2317/70 (EP);
C07K2317/76 (EP,CN,US); C07K2317/92 (EP,CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/14]
TitleGerman:ANTI-CANIN-PD-1-ANTIKÖRPER, DER AN CANINES PD-1 BINDET[2022/14]
English:ANTI-CANINE PD-1 ANTIBODY BINDING WITH CANINE PD-1[2022/14]
French:ANTICORPS ANTI-PD-1 CANIN SE LIANT À PD-1 CANIN[2022/14]
Entry into regional phase03.01.2022Translation filed 
03.01.2022National basic fee paid 
03.01.2022Search fee paid 
03.01.2022Designation fee(s) paid 
03.01.2022Examination fee paid 
Examination procedure03.01.2022Examination requested  [2022/14]
22.03.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
28.04.2022Renewal fee patent year 03
31.03.2023Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.06.202405   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]EP3168236  (NIPPON ZENYAKU KOGYO CO LTD [JP]) [I] 1-15 * paragraphs [0009] - [0011], [0018], [0028], [0030]; examples, figures 1, 3-9 *;
 [I]US2019002562  (MORSEY MOHAMAD [US], et al) [I] 1-15 * paragraphs [0002], [0024] - [0026]; [0059], [0230], table 14; examples *;
 [I]  - COY J. ET AL, "PD-1 expression by canine T cells and functional effects of PD-1 blockade", VETERINARY AND COMPARATIVE ONCOLOGY, Hoboken, USA, vol. 15, no. 4, doi:10.1111/vco.12294, ISSN 1476-5810, (20170125), pages 1487 - 1502, URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fvco.12294, XP093047224 [I] 1-15 * abstract, figures 1-8 *

DOI:   http://dx.doi.org/10.1111/vco.12294
 [A]  - RUDIKOFF S ET AL, "Single amino acid substitution altering antigen-binding specificity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, (19820301), vol. 79, no. 6, doi:10.1073/PNAS.79.6.1979, ISSN 0027-8424, pages 1979 - 1983, XP002683593 [A] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1073/pnas.79.6.1979
 [A]  - WINKLER K ET AL, "Changing the antigen binding specificity by single point mutations of an anti-p24 (HIV-1) antibody", THE JOURNAL OF IMMUNOLOGY, WILLIAMS & WILKINS CO, US, (20001015), vol. 165, no. 8, ISSN 0022-1767, pages 4505 - 4514, XP002579393 [A] 1-15 * abstract *
International search[X]CN105829344  (INTERVET INT BV) [X] 1, 10-13, 23 * see description, paragraphs 0011-0028, embodiment 2, claims *;
 [A]CN105829344  (INTERVET INT BV) [A] 2-9, 14-22 * see description, paragraphs 0011-0028, embodiment 2, claims *;
 [X]CN106029695  (INTERVET INT BV) [X] 1, 10-13, 23 * see description, paragraphs 0011-0051, 0115-0118, claims *;
 [A]CN106029695  (INTERVET INT BV) [A] 2-9, 14-22 * see description, paragraphs 0011-0051, 0115-0118, claims *;
 [X]CN106029697  (INTERVET INT BV) [X] 1, 10-13, 23 * see description, paragraphs 0011-0028, embodiment 2, claims *;
 [A]CN106029697  (INTERVET INT BV) [A] 2-9, 1-22 * see description, paragraphs 0011-0028, embodiment 2, claims *;
 [X]CN107074952  (INTERVET INT BV) [X] 1, 10-13, 23 * see description, paragraphs 0015-0082, claims *;
 [A]CN107074952  (INTERVET INT BV) [A] 2-9, 14-22 * see description, paragraphs 0015-0082, claims *;
 [PX]CN110194799  (BEIJING SINOGENE BIOTECHNOLOGY CO LTD) [PX] 1-23 * see claims *;
 [X]EP3168236  (NIPPON ZENYAKU KOGYO CO LTD [JP]) [X] 1, 10-13, 23 * see description, paragraphs 0009-0012, 0018, 0026, claims *;
 [A]EP3168236  (NIPPON ZENYAKU KOGYO CO LTD [JP]) [A] 2-9, 14-22* see description, paragraphs 0009-0012, 0018, 0026, claims *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.